Skip to main content
Government of Quebec
Institut national de santé publique du Québec
Français
FR
Home
Navigation principale
The Institute
The Institute
About us
About us
Products and services offered
Back
Contact us
Contact us
Workplaces
Back
Exit
Back
Expertise
Expertise
Information management and analysis
Information management and analysis
Deprivation
Deprivation
Indices of multiple and multidimensional deprivation
Material and Social Deprivation Index
Back
Back
Individual and community development
Individual and community development
Perinatal and early childhood
Perinatal and early childhood
From Tiny Tot to Toddler
Back
Back
Lifestyles
Lifestyles
Alimentation
Alimentation
Health-promoting environments
Back
Back
Psychoactive substances, tobacco and gambling
Psychoactive substances, tobacco and gambling
Drugs and medicines
Drugs and medicines
Opioid overdoses
Back
Tobacco and electronic cigarettes
Tobacco and electronic cigarettes
Science Watch : Tobacco Control
Back
Back
Infectious diseases
Infectious diseases
Respiratory infectious diseases
Respiratory infectious diseases
Données des virus respiratoires
COVID-19 (coronavirus)
Back
Prevention and control of healthcare-associated infections
Prevention and control of healthcare-associated infections
Nosocomial infections
Back
Travel-health
Travel-health
Health tips for travellers
Back
Zoonoses and emerging diseases
Zoonoses and emerging diseases
Diseases transmitted by ticks
Back
Back
Occupational health
Occupational health
Work-related respiratory diseases
Work-related respiratory diseases
Asbestos
Back
Psychosocial risks in the workplace
Psychosocial risks in the workplace
Let's get started
Back
Back
Indigenous Health
Indigenous Health
Research Monitoring
Research Monitoring
Methodology for Indigenous Health Research Monitoring
Back
Nunavik Inuit Health Survey 2004
Back
Environmental Health
Environmental Health
Air quality
Air quality
Indoor air
Back
Back
Safety, violence and injury prevention
Safety, violence and injury prevention
Community safety promotion
Community safety promotion
Methods and tools
Back
Prevention of interpersonal violence
Prevention of interpersonal violence
Sexual Violence
Rapport québécois sur la violence et la santé
Back
Back
Exit
Back
Services
Services
Centre de toxicologie du Québec
Centre de toxicologie du Québec
About the CTQ
About the CTQ
Contact us
Back
Services
Services
Test catalog
Analysis request forms
Shipping samples
PayPal Bill Payment
Back
External quality assessment schemes
External quality assessment schemes
AMAP: AMAP Ring Test for Persistent Organic Pollutants in Human Serum
Creatinine: Interlaboratory Comparison Program for Measurement of Serum Creatinine
OSEQAS: External Quality Assessment Scheme for Organic Substances in Urine
PCI: Interlaboratory Comparison Program for Metals in Biological Matrices
QMEQAS: Quebec Multielement External Quality Assessment Scheme
Back
Back
Infectious diseases
Infectious diseases
Blood-Borne Infection Risk Assessment Unit
Blood-Borne Infection Risk Assessment Unit
Risk Assessment Process
Rights and Responsibilities
Back
Back
Exit
Back
Publications
Publications
Publications
Subscribe to INSPQ's mailing lists
Exit
Back
Surveys
Surveys
Respiratory viruses survey
Exit
Back
Danger page
Search
Search by keywords
Content type
Content type
Data
Internship
Laboratory analysis
News
Newsletter
Page
Publication
Tiny Tot
Training
Marc Dionne
Publications
INSPQ
2025
Impact des maladies chroniques sur les taux d’utilisation des antibiotiques dans la communauté
2022
Enquête épidémiologique sur la situation de la lymphogranulomatose vénérienne (LGV) au Québec, données 2013-2019
Enquête épidémiologique sur les travailleurs de la santé atteints par la COVID-19 au printemps 2020
Utilisation communautaire d’antibiotiques – Projet de démonstration à partir des données du Système intégré de surveillance sur les maladies chroniques du Québec
2020
Faisabilité d’une surveillance de la résistance aux antibiotiques à partir des données de laboratoire extraites par un logiciel intégratif en centre hospitalier
2019
La communication des risques à la santé
2018
Démarrage du processus d’évaluation et de gestion des risques en santé publique : cadrer la situation de risque
La gestion des risques en santé publique au Québec : cadre de référence
Mémoire déposé à la Commission parlementaire sur les transports et l'environnement lors des consultations particulières et audiences publiques à l'égard du document Rapport sur les véhicules hors route – Vers un développement durable de la pratique
2016
Mesures générales de santé publique (en situation de pandémie d'influenza)
2010
La détection de l'infection gonococcique dans les laboratoires biomédicaux du Québec face à l'émergence de la résistance de N. Gonorrhoeae à la ciprofloxacine
2007
Caractéristiques des souches de Clostridium difficile au Québec en 2005 : impact sur l'incidence et la fréquence des complications des diarrhées associées au Clostridium difficile
Le dépistage de la syphilis chez la femme enceinte
L'utilisation de l'amiante chrysotile au Québec
2006
The Use of Chrysotile Asbestos in Quebec
2005
Aliments génétiquement modifiés et santé publique : document synthèse
Aliments génétiquement modifiés et santé publique : document technique
2001
Prévention de la légionellose et des brûlures en relation avec la température des chauffe-eau électriques domestiques
Chronic diseases and compliance with provincial guidelines for outpatient antibiotic prescription in cases of otitis media and respiratory infections: a population-based study of linked data in Quebec, Canada, 2010-2017
Chronic diseases and variations in rates of antimicrobial use in the community: a population-based analysis of linked administrative data in Quebec, Canada, 2002-2017
Scientific papers
2022
Chronic respiratory disease should be considered when interpreting indicators of community antimicrobial use in people over 65 years old
Trends in the use of laboratory tests for the diagnosis of Clostridium difficile infection and association with incidence rates in Quebec, Canada, 2010-2014
2020
Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial
2017
Long-term persistence of immunity after vaccination of pre-adolescents with low doses of a recombinant hepatitis B vaccine
2014
Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine
2013
Epidemiological patterns and hospital characteristics associated with increased incidence of Clostridium difficile infection in Quebec, Canada, 1998-2006
Setting priorities for new vaccination programs by using public health officers and immunization managers opinions
2010
A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec
2008
Why are some children incompletely vaccinated at the age of 2?
2007
Lack of conviction about vaccination in certain Quebec vaccinators
2003
Importance of attributable risk in monitoring adverse events after immunization: hepatitis B vaccination in children
2001
Molecular Confirmation of Hepatitis A Virus from Well Water: Epidemiology and Public Health Implications
La gestion des risques en santé publique – Cadre de référence québécois
1999
Aliments génétiquement modifiés et risques pour la santé
Others
2003
Protection contre les infections persistantes VPH 16/18 jusqu’à 13 ans après la vaccination de filles de 9-11 ans avec 2 ou 3 doses du vaccin quadrivalent selon un calendrier allongé : rapport de l’étude ICI-VPH
2002
Impact des maladies chroniques sur la prescription des antibiotiques selon les guides cliniques dans la communauté
Government of Quebec
Government of Quebec
